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We have evaluated the toxicity of four glyphosate (G)-based herbicides in Roundup (R) formulations,
from 10
5 times dilutions, on three different human cell types. This dilution level is far below agricultural
recommendations and corresponds to low levels of residues in food or feed. The formulations have been
compared to G alone and with its main metabolite AMPA or with one known adjuvant of R formulations,
POEA. HUVEC primary neonate umbilical cord vein cells have been tested with 293 embryonic kidney
and JEG3 placental cell lines. All R formulations cause total cell death within 24 h, through an inhibition
of the mitochondrial succinate dehydrogenase activity, and necrosis, by release of cytosolic adenylate
kinase measuring membrane damage. They also induce apoptosis via activation of enzymatic caspases
3/7 activity. This is conﬁrmed by characteristic DNA fragmentation, nuclear shrinkage (pyknosis), and
nuclear fragmentation (karyorrhexis), which is demonstrated by DAPI in apoptotic round cells. G provokes
only apoptosis, and HUVEC are 100 times more sensitive overall at this level. The deleterious effects
are not proportional to G concentrations but rather depend on the nature of the adjuvants. AMPA and
POEA separately and synergistically damage cell membranes like R but at different concentrations. Their
mixtures are generally even more harmful with G. In conclusion, the R adjuvants like POEA change
human cell permeability and amplify toxicity induced already by G, through apoptosis and necrosis. The
real threshold of G toxicity must take into account the presence of adjuvants but also G metabolism and
time-ampliﬁed effects or bioaccumulation. This should be discussed when analyzing the in vivo toxic
actions of R. This work clearly conﬁrms that the adjuvants in Roundup formulations are not inert.
Moreover, the proprietary mixtures available on the market could cause cell damage and even death
around residual levels to be expected, especially in food and feed derived from R formulation-treated
crops.
Introduction
Humans are exposed daily to a great number of xenobiotics
and their metabolites, present as pollutants (1). They act as
mixtures having compensatory, multiplicative, or synergistic
effects, as we have shown (2) with others (3, 4). The main
glyphosate (G) formulations, commercialized as Roundup (R)
from the Monsanto Company, are themselves already mixtures
of G and various adjuvants at different concentrations. We have
studied these products, which are the major nonselective
herbicides worldwide (5); moreover, their use and presence in
the food chain (6) are increasing since more than 75% of
genetically modiﬁed edible plants have been designed to tolerate
high levels of these compounds (7). G and its major metabolite
aminomethylphosphonic acid (AMPA) were classiﬁed among
the ﬁrst contaminants in rivers (8). The adjuvants, less measured
in the environment, are usually considered as inert and are
protected as a “trade secret” in manufacturing (9). However,
among them, the predominant one appears to be the polyethoxy-
lated tallowamine or POEA (10, 11), which has itself some
toxicity (12), such as causing ocular burns, redness, swellings
and blisters, short-term nausea, and diarrhea. In combination
with G, the mixture becomes more active (13). These products,
like detergents, could allow facilitated G penetration through
plasmatic membranes, potentialization of its action, increased
stability, and bioaccumulation (14, 15).
The dose- and time-dependent cytotoxicity of R Bioforce (360
g/L of G, R360) on human placental and embryonic cells (15)
could explain at least in part some reproductive problems (16).
Among the two lines, 293 embryonic cells have proven to be
very suitable for estimating the hormonal activity for xenobiotics
(17), and JEG3 cells are also considered a useful model for
examining placental toxicity (18). These lines may be equally
or even less sensitive to xenobiotics than primary cultures (19).
In the present study, we also tested the mechanism by which R
mixtures affect human primary cells of the umbilical vein cord
endothelial cells (HUVEC) for comparative purposes.
The endothelial lining of blood vessels constitutes a permeable
barrier between the blood and the underlying tissues. The
endothelium also plays an important role in various physiologi-
cal processes, such as metabolism of vasoactive substances and
maintenance of antithrombotic factors on the vessel wall (20).
The endothelial cells are exposed directly to chemicals circulat-
ing in the blood of the umbilical cord and pass through the
placenta (21). It is known that HUVEC cells may be a target
for adverse effects of xenobiotics activated into reactive
metabolites (22, 23). Other somatic cell types have been used
to study pesticide toxicity and apoptosis such as HeLa (24) and
Jurkat (25), but none was before treated by glyphosate.
In human cells, we have demonstrated that G mixed with
adjuvants in R360 was cytotoxic through alteration of succinate
dehydrogenase SD (14, 15). With isolated rat liver mitochondria,
it is demonstrated that R depresses the mitochondrial complexes
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checkpoints, and G with its adjuvants inhibited hatching enzyme
transcription synergistically (27, 28). Recently, it was shown
in this model to activate the DNA damage checkpoint CDK1/
cycline B of the ﬁrst cell cycle of development (29, 30) for
commitment to cell death by apoptosis in the case of failure of
DNA repair.
This work focuses on the cell death mechanism in human
cells induced by four different G formulations with a large
number of agricultural applications. We have chosen Roundup
Express (R7.2), Roundup Bioforce or Extra 360 (R360),
Roundup Grand Travaux (R400), and Roundup Grand Travaux
Plus (R450) at subagricultural dilutions. We tested them on three
important enzymatic biomarkers. First, at the membrane level,
we measured adenylate kinase (AK) activity after its release in
the medium (31), revealing cytoplasmic membrane rupture,
corresponding to a necrosis and/or a secondary necrosis at the
end of apoptosis (32). Second, at the mitochondrial respiration
level, we measured succinate dehydrogenase (SD) activity (33).
Third, we tested the cytosolic level with caspase 3 and 7
activities to determine the apoptosis pathway (34-36) and in
situ DNA fragmentation (DAPI). Necrosis is evinced by
cytoplasmic swelling, rupture of the plasma membrane, swelling
of cytoplasmic organelles (particularly mitochondria), and some
condensation of nuclear chromatin, whereas apoptosis is mani-
fested by cytoplasmic and nuclear condensation (pyknosis),
nuclear fragmentation (karyorrhexis), normal morphological
appearance of cytoplasmic organelles, and an intact plasma
membrane; following nuclear fragmentation, the cell disaggre-
gates into a number of membrane-bound apoptotic bodies
(37, 32). By contrast, cell death is now known to be perpetrated
through a variety of mechanisms. It can be classiﬁed into four
different types, based upon morphological characteristics: apo-
ptosis (type 1), autophagy (type 2), necrosis (oncosis, type 3),
and mitotic catastrophe (37).
The three human cell types allowed us to establish not only
the differential sensitivity of these models but also the general
human cell pathways of G-based pesticides actions from 1 ppm
(0.0001%); these were produced by G itself, its major metabolite
AMPA, and the main adjuvant POEA, singly or in combination.
Materials and Methods
Chemicals. N-Phosphonomethyl glycine (glyphosate, G, PM
169.07) and its major metabolite AMPA (PM 111.04) were
purchased from Sigma-Aldrich (Saint Quentin Fallavier, France).
Herbicide Roundup formulations (Monsanto, Anvers, Belgium)
were available on the market: Roundup Express 7.2 g/L of G,
homologation 2010321 (R7.2); Bioforce or Extra 360 at 360 g/L
of G, homologation 9800036 (R360); Grands Travaux 400 g/L
of G, homologation 8800425 (R400); and Grands Travaux plus
450 g/L of G, homologation 2020448 (R450). A 2% solution of
Roundup (1 or 2% is recommended by the company for
agricultural use) and an equivalent solution of glyphosate to
Roundup Bioforce were prepared in serum-free medium and
Figure 1. Cytotoxic effects of four Roundup formulations (R) on three human cell types. The R (from 10 to 2 × 10
4 ppm) contain different
glyphosate (G) concentrations (7.2, 360, 400, or 450 g/L) and adjuvants. G alone was used as control at equivalent quantities to R360 and at similar
pH 5.8. The cells were either primary from neonate umbilical cord (HUVEC) or lines from embryo (293) or placenta (JEG3). The actions on the
mitochondrial succinate dehydrogenase (SD) activity (cellular viability in %, A) and on the release of cytoplasmic adenylate kinase (AK) activity
[cell death in relative luminescence units (RLU), B] were compared in serum-free medium after 24 h of exposure. The 50% lethal dose (LD50)i s
indicated by a dashed line. SEs are shown in all instances (n ) 12).
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major adjuvant of Roundup, polyethoxylated tallowamine (POEA
at 785 g/L), was a gift from Pr. Robert Belle ´ (UMR 7150 CNRS/
UPMC, Station Biologique de Roscoff, France). Successive
dilutions were then obtained with serum-free medium. 4′,6′-
Diamidino-2-phenylindole, dihydrochloride (DAPI) nucleic acid
stain powder was obtained from Lonza (Saint Beauzire, France).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) and all other compounds, otherwise precised, were
obtained from Sigma-Aldrich. MTT was prepared asa5m g /
mL stock solution in phosphate-buffered saline, ﬁltered through
a 0.22 µm ﬁlter before use, and diluted to 1 mg/mL in a serum-
free medium.
Cell Cultures. Human Primary Cells. The human primary cells
used in this work were HUVEC (C2519A) provided by Lonza. Cells
(passage 5 or 6) were grown according to the supplier, in speciﬁc
endothelial growth medium EGM-2 SingleQuots (CC-4176) con-
taining hEGF, hydrocortisone, GA-1000 (Gentamicin, Amphoteri-
Figure 2. Nonlinear dose effects of R formulations. The LD50 (%) measured by SD are compared for the 4 R (see the Figure 1A legend) and G
for the three cell types in similar conditions.
Figure 3. Cytotoxicity of R adjuvant (POEA) and glyphosate (G) metabolite (AMPA) on three human cell types. G and R360 were used as controls
in similar conditions as in Figure 1 (see legend), in comparison to R adjuvant POEA and G metabolite AMPA (1-10
5 ppm). The 50% lethal dose
(LD50) is indicated by a dashed line. SEs are shown in all instances (n ) 12).
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ascorbic acid, and heparin. Fifty thousand cells per well were grown
at 37 °C (5% CO2, 95% air) over a 24 h period to 80% conﬂuence
in 48 well plates and were washed with serum-free EGM-2.
Human Cell Lines. The human embryonic kidney 293 cell line
(ECACC 85120602) and the human choriocarcinoma-derived
placental JEG3 cell line (ECACC 92120308) were provided by
CERDIC (Sophia-Antipolis, France). Cells were grown in phenol
red-free Eagle’s modiﬁed minimum essential medium (EMEM;
Abcys, Paris, France) containing 2 mM glutamine, 1% nonessential
amino acid, 100 U/mL antibiotics (a mix of penicillin, streptomycin,
and fungizone; Lonza), 10 mg/mL of liquid kanamycin (Dominique
Dutscher, Brumath, France), and 10% FBS (PAA, les Mureaux,
France). The JEG3 cell line was supplemented with 1 mM sodium
pyruvate. Fifty thousand cells per well were grown at 37 °C (5%
CO2, 95% air) over a 48 h period to 80% conﬂuence in 48 well
plates and were washed with serum-free EMEM.
Cell Treatments. Cells were exposed for 24 h in serum-free
medium to various dilutions of the different treatments including
the four Roundup formulations (R7.2, R360, R400, and R450), G,
AMPA, or POEA (14 concentrations from 10 ppm to 2%) and,
particularly for POEA, were tested at the very low concentrations
of 1 and 5 ppm; for AMPA, we tested in addition 4, 6, 8, and
10%. In another case, cells were incubated with G, AMPA, and
POEA mixtures by pairs at the ﬁnal nontoxic dilution on SD of
0.5% on the human cell lines (293 or JEG3) and 0.05% on the
human primary cells (HUVEC) in comparison to R360.
For the details, in each cell type, three combinations were studied.
For the two cell lines, the ﬁrst mixture was the combination of G
(0.4999%) with POEA (0.0001%); the second was the combination
of G (0.4%) with AMPA (0.1%), and the third was AMPA
(0.4999%) plus POEA (0.0001%). For the primary HUVEC cells,
the ﬁrst mixture was G (0.04999%) with POEA (0.0001%); the
second was G (0.04%) with AMPA (0.01%), and the third was
AMPA (0.04999%) plus POEA (0.0001%).
Cell Death Measurements. Mitochondrial Activity Mea-
surement. This measure was based on the cleavage of MTT into
a blue-colored product (formazan) by the mitochondrial enzyme
succinate dehydrogenase (38, 39, 33); it was used to evaluate human
cell viability. After cell treatments, the supernatants were recovered
for the ToxiLight bioassay, and adherent cells were washed with
serum-free medium and incubated with 200 µL MTT per well after
each treatment. The 48 well plates were incubated for3ha t3 7
°C, and 200 µL of 0.04 N hydrochloric acid-containing isopropanol
solution was added to each well. The plates were then vigorously
shaken to solubilize the blue formazan crystals formed. The optical
density was measured at 570 nm using a luminometer Mithras LB
940 (Berthold, Thoiry, France).
Cell Membrane Damage Assay. The bioluminescent ToxiLight
bioassay (Lonza) was a nondestructive cytotoxicity highly sensitive
assay designed to measure toxicity in mammalian cells and cell
lines in culture. It quantitatively measured the release of cytosolic
AK from the membranes of damaged cells (40, 31). AK is a robust
protein present in all eukaryotic cells, which is released into the
culture medium when cells die, described as an important necrosis
marker. The enzyme actively phosphorylated ADP, and the resultant
ATP was then measured using the bioluminescent ﬁreﬂy luciferase
reaction with the ToxiLight reagent. After 24 h of different
treatments, 50 µL of cell supernatants was deposited in 96 well
black plates. Then, 50 µL of the AK detection reagent (AKDR)
was added by well. Plates were then placed under agitation for 15
min safe from the light, and then, luminescence was measured using
the luminometer Mithras LB 940 (Berthold) at 565 nm. The serum-
free medium was the negative control, and a positive control was
the active reagent AKDR mixed with cells treated in the serum-
free medium to determine the basal activity.
Figure 4. Combined effects of G, AMPA, and POEA on three human cell types. The cells were incubated in serum-free medium for 24 h, and the
products were tested by pairs to a ﬁnal concentration, where they are nontoxic alone on succinate dehydrogenase, of 0.05 (HUVEC) and 0.5% (293,
JEG3). Results of cellular death are evaluated through AK activity in relative units in comparison to nontreated cells (control ) 1), and values are
blank-subtracted (blank ) no AK); see the Materials and Methods. R360 and G are used as controls. SEs are shown in all instances (n ) 16;
**p < 0.01).
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assay (Promega, Paris, France) was a luminescent kit designed for
automated high-throughput screening of caspases activity or apo-
ptosis. It can measure caspase 3 and 7 activities in puriﬁed enzyme
preparations or cultures of adherent or suspension cells (41, 42, 36).
The assay provided a pro-luminescent caspase 3/7 substrate, which
contains the tetrapeptide sequence DEVD active group. This
substrate was cleaved to release amino-luciferin, a substrate of
luciferase used in the production of light. The Caspase-Glo 3/7
reagent was optimized for caspase activity, luciferase activity, and
cell lysis. The addition of the single Caspase-Glo 3/7 reagent, in
an “add-mix-measure” format, resulted in cell lysis followed by
caspase cleavage of the substrate and generation of a “glow type”
luminescent signal. The Caspase-Glo 3/7 bioassay was carried out
in 96 well white plates.
After cell cultures and their treatments by 50 µL of various
dilutions, an equal volume of the reagent was added to each well.
Plates were then agitated for 15 min safe from the light, to stabilize
the light signal before measuring luminescence. Again, the negative
control was the serum-free medium, and the positive control was
the active reagent mixed with cells treated in the serum-free medium
to determine the basal activity of the caspases 3/7. Luminescence
was measured using the luminometer Mithras LB 940 (Berthold)
at 565 nm.
Cell Microscopy. At the end of the 24 h cell treatment, the
serum-free medium was removed, and cells were ﬁxed in absolute
ethanol-chloroform-acetic acid (6:3:1, v/v/v) for 1 day at -20
°C. Each well was washed with PBS (pH 7.4) and incubated with
1 µg/mL DAPI solution (43). Staining of DNA with DAPI was
examined with a microscope using a ﬂuorescent mode (model Leïca
LMD 6000, Rueil Malmaison, France). Labeled DNA of viable
cells was scattered throughout the nucleus, and bright condensation
of chromatin revealed apoptotic cells (magniﬁcation, 400×). At
the end of the cell treatment, the microphotographs (magniﬁcation,
100×; blue ﬁlter) of cells without coloration were also obtained
with the Leïca Microscopy Systems (model Leïca DC 100,
Germany).
Statistical Analysis. The experiments were repeated at least three
times during different weeks on three independent cultures each
time. All data were presented as the means ( standard errors (SEs).
Statistical differences were determined by a Student’s t test using
signiﬁcant levels of 0.01 (**).
Results
We have studied for the ﬁrst time the mechanism of cellular
action of different R on human cells, from placenta, embryonic
kidney, and neonate. The ﬁrst surprising results show that the
four R herbicides and G cause cellular death for all types of
human cells, with comparable toxicity for each one but at
different concentrations. For instance, 20 ppm for R400 at 24 h,
Figure 5. Time-dependent apoptosis through caspases 3/7 induction by R and G in three human cell types. R360 and G, at similar concentrations
and pH (as in Figure 1), were incubated for 6, 12, 18, or 24 h. The apoptotic pathway was tested by the Caspase-Glo 3/7 assay, and results are
presented in relative units to nontreated cells (control ) 1). SEs are shown in all instances (n ) 8).
Glyphosate Formulations Toxicity in Human Cells Chem. Res. Toxicol., Vol. 22, No. 1, 2009 101the most toxic, corresponds approximately to 47 µM G (8 ppm)
with adjuvants (Figure 1). However, 4-10 ppm G alone is
nontoxic; its toxicity begins around 1%. The mechanism is
constant for all R: There is a release of AK, indicative of cell
membrane damage, and an inhibition of the mitochondrial SD
(Figure 1). For all R, the membrane damage (AK) is 1.5-2
times more sensitive than mitochondrial activity (SD) for 293
and JEG3 or equally sensitive for HUVEC. By contrast, G
induces mitochondrial toxicity without cell membrane damage.
Unexpectedly, R400 is more toxic than another formulation
containing more G, such as R450; the latter is in turn more
harmful than R360, R7.2, and G in last, but all of them are
detrimental nonproportionally to the G concentration that they
contain. This is illustrated in Figure 2.
The mitochondrial SD inhibition measures cell asphyxia. It
is obvious from Figure 2 that 7.2 or 360 g/L G with adjuvants
in R formulations has closely comparable actions on cell death,
while 400 or 450 g/L gives inversely proportional effects in
another range. This is not an artifact since the embryonic and
placental cell lines behave remarkably similarly in that regard
and the primary umbilical cord cells have sensitivity for all R
and G just analogous to these cell lines (Figure 2). The mortality
in all cases is not linearly linked to G. The hypothesis that other
substances are implicated has thus to be investigated in the
formulation of the product.
Consequently, the major G metabolite, AMPA, and the
surfactant POEA, the main claimed adjuvant by the manufac-
turer (the exact composition is a secret of formulation), have
been tested separately in a ﬁrst approach, in comparison to G
and R360 as controls, and in similar conditions as in Figure 1,
from very low subagricultural dilutions (10
-6 if used pure like
claimed by some farmers and 10
-4 if diluted as recommended
at 1%).
G is claimed by the manufacturer to be the active ingredient,
and it is claimed to be not toxic for human cells but toxic for
vegetable ones when mixed with inert components. Our study
demonstrates for the ﬁrst time that all products including AMPA
and POEA provoke SD and AK effects in human cells, and
thus mortality (Figure 3), but at different concentrations.
Astonishingly, the supposed inert product POEA is the most
potent one. From 1 ppm, it begins to alter SD in HUVEC and
AK in 293 and JEG3. The mixture R is then more poisonous
than G or AMPA. The metabolite AMPA itself destroys the
cell membrane (AK release), whatever the cell type. This is
not observed with G, which is, however, 3-8 times more
inhibitory on SD than AMPA, with some differences between
cells. However, because the cell membrane damage is generally
more sensitive, the metabolite AMPA is ﬁnally more toxic than
G on human cells. POEA is the most toxic; if it was the only
adjuvant of R360, its maximal concentration would be around
1-24 ‰, according to the cells. Thus, POEA could be
considered as the active ingredient on human cell death and
more damaging than G. As R is more viscous than 1‰ POEA
plus G, it is obvious that other compounds are in the mixture.
Thus, it was necessary to study the combined effects on cell
membrane integrity (by AK release). We have tested the
compounds by pairs at maximal levels where alone they do not
inﬂuence SD (Figure 4). This was to assess the respective role
of each one, knowing that R contains all tested compounds when
metabolized. In contrast to previous results, the cells reacted
differently. The mixtures were more disrupting on embryonic
and umbilical cells, respectively, while placental carcinoma cells
appeared to be more membrane-resistant but to mixtures only.
It is very clear that if G, POEA, or AMPA has a small toxic
effect on embryonic cells alone at low levels, the combination
of two of them at the same ﬁnal concentration is signiﬁcantly
deleterious (Figure 4).
We have thus elucidated that R- and G-induced cell death
can be due, at least in part, to apoptosis via caspases 3/7
induction (Figure 5). The caspases are activated from 6 h with
a maximum at 12 h in all cases, but umbilical primary cells are
60-160 times more sensitive than lines (293 and JEG3,
respectively) at this level. Moreover, G and R360 enhance
exactly at the same concentration caspases, from 50 ppm
(HUVEC). The adjuvants do not appear to be necessary to
render G as a death inducer at this level. Even G alone is 30%
more potent on this pathway than R. Surprisingly, G acted very
rapidly at concentrations 500-1000 times lower than agricultural
use on human cell apoptosis. This apoptotic pathway was also
activated at levels 200 times lower for G on caspases than its
action on SD for umbilical cells, and for R at levels 60 times
lower, in a four times shorter period (6-24 h). After 24 h of
treatment, the caspases returned to basal level when SD and
AK react signiﬁcantly. These data are consistent with a gradual
loss of caspases 3/7 activity in apoptotic cells that undergo
secondary necrosis in vitro (44).
Our results are conﬁrmed by the morphology of the cells after
treatment by R (for instance R400, Figure 6B,D,E) in compari-
son with the normal cell types (A, C, F). Indeed, the very weak
R concentration of 0.005% causes a very important cell death,
lack of adhesion, shrinking, and fragmentation in apoptotic
bodies. This is conﬁrmed in Figure 7 with the DNA ﬂuorescent
labeling with DAPI, for example, with R360 at 0.5% over 24 h.
The characteristic ﬂuorescence of apoptotic cells evidencing
Figure 6. Microphotographs of R-treated human cells. The cell types
were without coloration (magniﬁcation, 100×; blue ﬁlter), HUVEC
(A, B), 293 (C, D), and JEG3 (E, F), and were incubated with 0.005%
of R400 or not (controls) in serum-free medium for 24 h. Micropho-
tographs were obtained with the Leïca Microscopy Systems (model
Leïca DC 100).
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controls (A, D, G) and more after R treatment (C, F, I) than
with G alone (B, E, H), for cell lines. The primary cells are
similarly sensitive to G than to R, as for caspases activation in
Figure 5.
Discussion
We had previously demonstrated (14) that G-based formula-
tions were able to affect human placental cell viability at
subagricultural doses (0.1% in 18 h) and sexual steroid
biosynthesis at lower nontoxic doses (0.01%) and that this was
due at least in part to G, but its action was highly ampliﬁed by
adjuvants, the so-called inert ingredients of R formulations, kept
conﬁdential by the companies (9). However, the question of a
speciﬁc cell line action or a time reversible effect remained open.
Benachour et al. (15) demonstrated that in embryonic cells as
well as in normal human placenta and equine testis, there was
a similar G-dependent endocrine disruption, through aromatase
inhibition, at nontoxic levels. The embryonic cells were even
more sensitive: It was discovered that the cell mitochondrial
activity was also reached in time- and dose-dependent manners
by the G formulation R360. The cytotoxicity was ampliﬁed
around 14 times between 24 and 72 h (15), suggesting either a
bioaccumulation or a time-delayed effect and suggesting a
cumulative impact, after endocrine disruption, of very low doses
around G acceptable daily intake (ADI: 0.3 mg/kg/j), according
to the nature of the adjuvants.
To understand in vivo effects through the interpretation of
the in cell impacts described above, it is necessary to have
knowledge of the dilution and of the processes leading to an
elimination of the product in the body. This must be taken into
account in regard to its bioaccumultation potential and time-
delayed effects. This is why we have measured the caspases
activities at different times and G or R concentrations, after
having previously demonstrated their effects ampliﬁed with time
within 3 days, on SD in embryonic and placental cells (15).
Moreover, the metabolism of the herbicide has to be considered,
and the tests in this study of all the above-cited products
approach this question.
All cell types, including primary cultures, react similarly at
the membrane and mitochondrial level, justifying the hypothesis
that the cell lines used provide excellent models to study human
cell toxicity, for instance in placental cells (18). We show for
the ﬁrst time that embryonic and umbilical cells also have
comparable sensitivity. The most reactive level reached appears
to be the cell membrane level for the different formulations,
but not for G. The supposed “inert ingredients” play obviously
and differently the role of cell membrane disruptors, indepen-
dently to G, as we have previously proposed (14), and this was
suggested in ﬁsh, amphibians, and microorganisms (27, 45)o r
in plants (46). We now demonstrate that in human cells.
The second level is the mitochondrial membrane and the
enzymatic reaction in it, SD, localized in the internal membrane
in complex II of the respiratory chain (47). It is altered in a
comparable way, not proportional to G but relatively to the
nature and the quantity of the adjuvants that we have previously
listed (15). This means that the toxicity of G clearly varies with
formulations that must imperatively now be used in in vivo tests
to study any toxicity (45); this also means that the ADI of G
must take into account its formulation, since 7.2 or 360 g/L of
G may have comparable effects, considerably different to 400
g/L. It would even be more correct to use precisely an ADI of
R instead of G. It may also be time-dependent. These ideas are
not taken into account yet for regulatory legislation.
The necessity to study combined effects also appears from
our results. In fact, the body is always exposed to mixtures and
not to single compounds. We have previously demonstrated that
mixtures could amplify toxicity for other widely spread pollut-
ants (2). For embryonic or neonatal cells, POEA, the major
adjuvant, has the highest toxicity, either by itself or ampliﬁed
2-5 times in combination with G or AMPA. It has already been
shown that POEA is highly toxic for sea urchin embryos,
impinging on transcription (28). It is also known that in an
Figure 7. Increase of DNA condensation (DAPI test) in R360- or G-treated human cells. The cell types HUVEC (A-C), 293 (D-F), and JEG3
(G-I) were incubated for 24 h with or without 0.5% R360 or G at equivalent concentrations. Staining of DNA with DAPI was examined with a
microscope model Leïca LMD 6000, using a ﬂuorescent mode. Labeled DNA of viable cells was scattered throughout the nucleus, and bright
condensation of chromatin revealed apoptotic cells (magniﬁcation, 400×).
Glyphosate Formulations Toxicity in Human Cells Chem. Res. Toxicol., Vol. 22, No. 1, 2009 103aquatic environment, POEA has higher effects than R and G
on bacteria, microalgae, protozoa, and crustaceans (12). In
addition, the known metabolism of G in the soil or plants is
supposed to detoxify it in AMPA (11); however, here, we
demonstrate that AMPA is more toxic than G in human cells,
especially on cell membrane. AMPA is also more stable in soil
(48), in plants, and in food or feed residues (49), and more
present in wastewater (2-35 ppm) than G [0.1-3 ppm; (50)].
It is not toxic alone at these concentrations in our experiments,
but it ampliﬁes G or POEA toxicity in combination. The
synergic toxicity of all of these compounds is now more obvious.
The induced resistance of placental cancer cells (51) could
explain a speciﬁc difference for JEG3 cells at these levels. The
placental cells could form an efﬁcient barrier to mixtures before
their death, since the membranes are more resistant, and this
could be due to the fact that there are carcinoma-derived cells
that have acquired a capacity to excrete xenobiotics.
The caspases 3/7 inducing apoptosis were in fact activated
ﬁrst within 6 h, and then, they decreased with cell mortality.
This corroborates the timing observed for another compound
(36). The caspases induction by G alone is observed at doses
that do not provoke cell or mitochondrial membrane damages,
indicating a clear G-apoptotic pathway always at subagricultural
doses. Mixed with adjuvants, G in R formulations reached the
other end points. This suggests that the adjuvants could also
play a role in total cell death, through necrosis characterized
by organelle alterations with mitochondrial and cell membranes
swelling and ruptures (52). The most sensitive are umbilical
HUVEC cells, for which apoptosis has been described (53-55),
but very rarely induced by a pesticide, for example, in the case
of diallyl trisulﬁde (56). Surprisingly, this phenomenon was
observed for G and R at similar and low concentrations, as if a
cell membrane death receptor was activated (57, 32), with no
G penetration necessary. The modiﬁcation of a dependency
receptor is another pathway that could be studied (58). The
apoptotic cell appearance was microscopically conﬁrmed. Then,
our next step could be to study the necrotic/apoptotic ratio within
short times.
In conclusion, mixtures called “formulations” change cell
permeability, toxicity, and pathways of xenobiotics: In all cases,
cell death is induced more by R than by AMPA or G, and the
latter provokes apoptosis (from 50 ppm in HUVEC cells)
without membrane damage. By contrast, G mixed with adjuvants
in R formulations disrupts cell and mitochondrial membranes
and promotes necrosis. It becomes obvious that the “threshold”
level of action of the herbicide should take into account the
period and length of exposure, the presence of adjuvants, in
particular POEA, metabolism, and bioaccumulation or time-
delayed effects. All of the above effects are demonstrated below
the recommended herbicide agricultural dilutions (from 10
4
ppm). This clearly conﬁrms that the adjuvants in Roundup
formulations are not inert. Moreover, the proprietary mixtures
available on the market could cause cell damage and even death
around residual levels to be expected, especially in food and
feed derived from R formulation-treated crops.
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